The T1D Exchange Registry

Last updated: May 4, 2023
Sponsor: T1D Exchange, United States
Overall Status: Active - Recruiting

Phase

N/A

Condition

Diabetic Neuropathy

Diabetes Prevention

Diabetic Vitreous Hemorrhage

Treatment

No intervention

Clinical Study ID

NCT04629586
1822333
  • All Genders

Study Summary

The T1D Exchange Registry is a research study, conducted over time, for individuals with type 1 diabetes and their supporters. Participants volunteer to provide their data for research (for example, by answering questions in annual surveys). Once enrolled, Registry participants have the opportunity to sign up for other studies on various topics related to type 1 diabetes.

To participate, you will be asked to:

  • Read and sign an online informed consent form

  • Take a survey describing specific demographic and type 1 diabetes management information

  • Update your information annually

  • Periodically opt in for additional research opportunities (if you choose), i.e. taking new surveys or uploading health device data

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Clinical diagnosis of type 1 diabetes.
  • Individuals younger than 18 years of age must have parent/guardian consent.
  • Must be able to read and understand English.
  • Currently living in the United States

Exclusion

Exclusion criteria:

  • Does not use insulin and has not had a pancreatic or islet cell transplant.
  • Cannot fully read and understand English.
  • Does not currently live in the United States.

Study Design

Total Participants: 50000
Treatment Group(s): 1
Primary Treatment: No intervention
Phase:
Study Start date:
December 13, 2018
Estimated Completion Date:
December 31, 2030

Connect with a study center

  • T1D Exchange

    Boston, Massachusetts 02111
    United States

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.